Heart Failure News and Research

RSS

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.

Sacubitril/valsartan therapy may reduce hospitalization in heart patients with preserved ejection fraction

Sacubitril/valsartan reduces NT-proBNP, a biomarker predictive of long-term clinical outcomes in heart failure, but does not improve functional capacity compared to individualized background therapy in patients with heart failure with preserved ejection fraction

1 Sep 2020

Majority of U.S. COVID-19 fatalities had underlying medical conditions

Early on in the coronavirus disease (COVID-19) pandemic, there was little data on the virus and how it affects the body. As the virus spread across the globe, data showed that some people were at a higher risk of developing severe disease and dying from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

31 Aug 2020

COVID-19 patients may experience long-term cardiovascular complications

Researchers at the University of Washington in Seattle have conducted a study suggesting that infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can directly infect heart tissue and contribute to whole-organ cardiac dysfunction.

31 Aug 2020

Blood pressure medication could be an effective tool for reducing cardiovascular risk

Blood pressure medication can prevent heart attacks and strokes - even in people with normal blood pressure. That's the finding of late breaking research presented in a Hot Line session today at ESC Congress 2020.

31 Aug 2020

Wearable device may more accurately assess the effects of hemorrhage blood loss

Emergency medical technicians (EMTs), military medics, and emergency room physicians could one day be better able to treat victims of vehicular accidents, gunshot wounds, and battlefield injuries thanks to a new device under development that may more accurately assess the effects of blood loss due to hemorrhage.

31 Aug 2020

SGLT2 inhibitors can slow CKD progression

850 million people worldwide are affected by chronic kidney disease (CKD) - a worrying figure, and one that continues to rise.

31 Aug 2020

Telemonitoring may reduce heart attack, stroke rate by 50% for people with high blood pressure

People enrolled in a pharmacist-led telemonitoring program to control high blood pressure were about half as likely to have a heart attack or stroke compared to those who received routine primary care, according to new research published today in Hypertension, an American Heart Association journal.

31 Aug 2020

Hestia criteria, sPESI score can be used to select pulmonary embolism patients for outpatient care

Patients with acute pulmonary embolism can be selected for home management using the sPESI score or the Hestia criteria, according to results of the HOME-PE trial presented in a Hot Line session today at ESC Congress 2020.

31 Aug 2020

$Empagliflozin reduces risk of death in patients with heart failure and reduced ejection fraction$

Heart Failure News and Research

Further Reading

Sacubitril/valsartan therapy may reduce hospitalization in heart patients with preserved ejection fraction

Majority of U.S. COVID-19 fatalities had underlying medical conditions

COVID-19 patients may experience long-term cardiovascular complications

Blood pressure medication could be an effective tool for reducing cardiovascular risk

Wearable device may more accurately assess the effects of hemorrhage blood loss

SGLT2 inhibitors can slow CKD progression

Telemonitoring may reduce heart attack, stroke rate by 50% for people with high blood pressure

Hestia criteria, sPESI score can be used to select pulmonary embolism patients for outpatient care

Empagliflozin reduces risk of death in patients with heart failure and reduced ejection fraction

Patients with newly diagnosed atrial fibrillation benefit from early rhythm control therapy

Study: Mavacamten improves heart function in patients with hypertrophic cardiomyopathy

DAPA-CKD trial shows dapagliflozin reduces risk of chronic kidney disease

Researchers identify roles of matrix stiffness and mechanotransduction in cardiac reprogramming

High blood pressure can be treated without causing erectile dysfunction, shows study

Influenza, pneumonia vaccinations associated with fewer deaths in heart failure patients

MedAxiom release its eighth annual cardiovascular provider compensation and production survey

Gout drug may improve heart function in individuals with congenital heart disease

AstraZeneca partners with World Heart Federation to reduce the global burden of heart failure

Anticoagulation therapy associated with improved survival among COVID-19 patients

Cognitive impairment linked to increased risk of rehospitalization in heart failure patients

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News